Puma Bio (PBYI) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

Puma Bio Revenue Highlights


Latest Revenue (Y)

$235.64M

Latest Revenue (Q)

$47.08M

Main Segment (Y)

Royalty

Main Geography (Y)

Royalty

Puma Bio Revenue by Period


Puma Bio Revenue by Year

DateRevenueChange
2023-12-31$235.64M3.35%
2022-12-31$228.00M-9.95%
2021-12-31$253.20M12.48%
2020-12-31$225.10M-17.33%
2019-12-31$272.30M8.49%
2018-12-31$251.00M806.14%
2017-12-31$27.70M100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31-100.00%
2012-12-31--100.00%
2011-12-31$-281.10K100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31--

Puma Bio generated $235.64M in revenue during NA 2023, up 3.35% compared to the previous quarter, and up 93.88% compared to the same period a year ago.

Puma Bio Revenue by Quarter

DateRevenueChange
2024-06-30$47.08M7.58%
2024-03-31$43.77M-39.36%
2023-12-31$72.18M28.62%
2023-09-30$56.12M2.84%
2023-06-30$54.57M3.40%
2023-03-31$52.77M-19.67%
2022-12-31$65.70M15.06%
2022-09-30$57.10M-4.06%
2022-06-30$59.52M30.13%
2022-03-31$45.74M-17.44%
2021-12-31$55.40M19.80%
2021-09-30$46.24M-13.37%
2021-06-30$53.38M-45.62%
2021-03-31$98.17M86.63%
2020-12-31$52.60M3.64%
2020-09-30$50.75M-28.09%
2020-06-30$70.58M37.81%
2020-03-31$51.22M-18.57%
2019-12-31$62.90M11.52%
2019-09-30$56.40M4.60%
2019-06-30$53.92M-45.59%
2019-03-31$99.10M39.38%
2018-12-31$71.10M13.58%
2018-09-30$62.60M23.31%
2018-06-30$50.77M-23.68%
2018-03-31$66.52M207.94%
2017-12-31$21.60M255.44%
2017-09-30$6.08M100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31--

Puma Bio generated $47.08M in revenue during Q2 2024, up 7.58% compared to the previous quarter, and up 89.21% compared to the same period a year ago.

Puma Bio Revenue Breakdown


Puma Bio Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 20Dec 19Dec 18
License$2.50M$60.25M$50.50M
Royalty$5.68M$391.00K-
Product-$211.62M$200.49M

Puma Bio's latest annual revenue breakdown by segment (product or service), as of Dec 20: Royalty (69.45%), and License (30.55%).

Quarterly Revenue by Product

Product/ServiceJun 24Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18
Product$44.40M$48.86M$50.02M$48.77M$48.61M$58.71M$53.48M$53.86M$45.57M$61.08M$52.63M$50.77M--
Royalty$2.69M$4.28M$2.35M$2.54M$1.42M$1.11M$608.00K$216.00K$120.00K$55.00K----
License-$250.00K$2.50M$2.70M$20.70M$2.00M$4.00M$2.75M-$53.50M$10.00M$10.00M$30.50M-

Puma Bio's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (94.29%), and Royalty (5.71%).

Puma Bio Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 20Dec 19Dec 18
Royalty$5.68M$391.00K-
License$2.50M$60.25M$50.50M
Product-$211.62M$200.49M

Puma Bio's latest annual revenue breakdown by geography, as of Dec 20: Royalty (69.45%), and License (30.55%).

Quarterly Revenue by Country

CountryJun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18
Royalty$4.28M$2.35M$2.54M$1.42M$1.11M$608.00K$216.00K$120.00K$55.00K----
Product$48.86M$50.02M$48.77M$48.61M$58.71M$53.48M$53.86M$45.57M$61.08M$52.63M$50.77M--
License$250.00K$2.50M$2.70M$20.70M$2.00M$4.00M$2.75M-$53.50M$10.00M$10.00M$30.50M-

Puma Bio's latest quarterly revenue breakdown by geography, as of Jun 21: Product (91.52%), Royalty (8.01%), and License (0.47%).

Puma Bio Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
SRPTSarepta Therapeutics$1.24B$413.46M
PTCTPTC Therapeutics$937.82M$186.70M
RAREUltragenyx Pharmaceutical$434.25M$147.03M
CHRSCoherus BioSciences$257.24M$64.98M
PBYIPuma Bio$235.64M$47.08M
HRTXHeron Therapeutics$127.04M$46.54M
TSVT2seventy bio$100.39M$8.97M
ARVNArvinas$78.50M$102.40M
MGNXMacroGenics$58.75M$10.80M
RVMDRevolution Medicines, Inc. Warrant$11.58M-
CRNXCrinetics Pharmaceuticals$4.01M$640.00K
IOVAIovance Biotherapeutics$1.19M$31.11M
VKTXViking Therapeutics--
KURAKura Oncology--
MDGLMadrigal Pharmaceuticals-$62.17M
LRMRLarimar Therapeutics--
HEPAHepion Pharmaceuticals--

PBYI Revenue FAQ


Puma Bio's yearly revenue for 2023 was $235.64M, representing an increase of 3.35% compared to 2022. The company's yearly revenue for 2022 was $228M, representing a decrease of -9.95% compared to 2021. PBYI's yearly revenue for 2021 was $253.2M, representing an increase of 12.48% compared to 2020.

Puma Bio's quarterly revenue for Q2 2024 was $47.08M, a 7.58% increase from the previous quarter (Q1 2024), and a -13.72% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $43.77M, a -39.36% decrease from the previous quarter (Q4 2023), and a -17.07% decrease year-over-year (Q1 2023). PBYI's quarterly revenue for Q4 2023 was $72.18M, a 28.62% increase from the previous quarter (Q3 2023), and a 9.86% increase year-over-year (Q4 2022).

Puma Bio's revenue growth rate for the last 3 years (2021-2023) was -6.94%, and for the last 5 years (2019-2023) was -13.46%.

Puma Bio's revenue streams in c 20 are License, and Royalty. License generated $2.5M in revenue, accounting 30.55% of the company's total revenue, down -95.85% year-over-year. Royalty generated $5.68M in revenue, accounting 69.45% of the company's total revenue, up 1353.20% year-over-year.

For the fiscal year ending Dec 20, the largest source of revenue of Puma Bio was Royalty. This segment made a revenue of $5.68M, representing 69.45% of the company's total revenue.